WLLW Stock Overview
A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Willow Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.11 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.06 |
| Beta | 1.07 |
| 1 Month Change | 29.41% |
| 3 Month Change | 10.00% |
| 1 Year Change | -12.00% |
| 3 Year Change | -91.06% |
| 5 Year Change | -93.17% |
| Change since IPO | -96.33% |
Recent News & Updates
Recent updates
Is Willow Biosciences (TSE:WLLW) In A Good Position To Deliver On Growth Plans?
Apr 11
We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully
Dec 20We Think Willow Biosciences (TSE:WLLW) Can Afford To Drive Business Growth
Sep 02We Think Willow Biosciences (TSE:WLLW) Can Easily Afford To Drive Business Growth
May 20Calculating The Fair Value Of Willow Biosciences Inc. (TSE:WLLW)
Jan 19Shareholder Returns
| WLLW | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 37.5% | 7.1% | -1.4% |
| 1Y | -12.0% | -28.0% | 11.2% |
Return vs Industry: WLLW exceeded the Canadian Biotechs industry which returned -28% over the past year.
Return vs Market: WLLW underperformed the Canadian Market which returned 11.2% over the past year.
Price Volatility
| WLLW volatility | |
|---|---|
| WLLW Average Weekly Movement | 15.3% |
| Biotechs Industry Average Movement | 11.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: WLLW's share price has been volatile over the past 3 months.
Volatility Over Time: WLLW's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 19 | Chris Savile | www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
| WLLW fundamental statistics | |
|---|---|
| Market cap | CA$14.64m |
| Earnings (TTM) | -CA$10.62m |
| Revenue (TTM) | CA$949.00k |
14.8x
P/S Ratio-1.3x
P/E RatioIs WLLW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WLLW income statement (TTM) | |
|---|---|
| Revenue | CA$949.00k |
| Cost of Revenue | CA$6.80m |
| Gross Profit | -CA$5.85m |
| Other Expenses | CA$4.77m |
| Earnings | -CA$10.62m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.083 |
| Gross Margin | -616.54% |
| Net Profit Margin | -1,118.76% |
| Debt/Equity Ratio | 44.4% |
How did WLLW perform over the long term?
See historical performance and comparison